Confirming previous findings [14], The Cancer Genome Atlas (TCGA) study reported that the tumor suppressors BAP1, CDKN2A, NF2, TP53, LATS2, and SETD2 were among the most frequently mutated in 74 PMs samples. This evidence concerns the gene TP53 and neoplasm.